ICD아이씨디
040910 · KOSDAQ · ₩040910 · 아이씨디
₩3,770▼ ₩60 (1.57%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩197B | ₩148B | ₩62B | ₩151B | ₩116B |
| Cost of sales | ₩164B | ₩151B | ₩68B | ₩135B | ₩92B |
| Gross profit | ₩33B | −₩3.1B | −₩5.5B | ₩16B | ₩24B |
| Operating income | ₩4.5B | −₩27B | −₩37B | −₩5.1B | ₩1.7B |
| Net income | −₩2B | −₩28B | −₩37B | −₩5.4B | ₩762M |
| Net income to shareholders | −₩1.9B | −₩28B | −₩37B | −₩5.4B | ₩762M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩144B | ₩191B | ₩210B | ₩203B | ₩233B |
| Current assets | ₩80B | ₩120B | ₩122B | ₩113B | ₩135B |
| Cash and equivalents | ₩8.4B | ₩23B | ₩28B | ₩23B | ₩47B |
| Total liabilities | ₩46B | ₩94B | ₩79B | ₩49B | ₩65B |
| Current liabilities | ₩43B | ₩78B | ₩71B | ₩43B | ₩57B |
| Borrowings | ₩18B | ₩33B | ₩14B | ₩22B | ₩17B |
| Total equity | ₩98B | ₩97B | ₩131B | ₩153B | ₩168B |
| Shareholders' equity | ₩99B | ₩97B | ₩131B | ₩153B | ₩168B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩8B | −₩28B | −₩1.5B | −₩14B | ₩21B |
| Capital spending | ₩693M | — | — | — | — |
| Free cash flow | ₩7.3B | −₩28B | −₩1.5B | −₩14B | ₩21B |
| Dividends paid | — | — | ₩1.6B | ₩3.3B | ₩5.9B |
Consolidated where available. Amounts in won.
Also known as: ICD / 아이씨디 / 040910 / KRX:040910
Source: KRX statistical information